Asthma

FILE - This Oct. 14, 2015, file photo shows the Food and Drug Administration campus in Silver Spring, Md. The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators. The FDA on Wednesday, Jan. 30, 2019, approved Mylan's version in three strengths for ages 4 and up. (AP Photo/Andrew Harnik, File)
January 30, 2019 - 6:44 pm
The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators. The Food and Drug Administration on Wednesday approved Mylan's version in three strengths for ages 4 and up. The inhalers are used twice daily to keep airways open and prevent flare-ups of wheezing...
Read More
This undated product image provided by Amphastar shows Primatene Mist. A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores. The Food and Drug Administration on Wednesday, Nov. 7, 2018, approved its over-the-counter aerosol inhaler for ages 12 and up. (Amphastar via AP)
November 08, 2018 - 11:13 am
TRENTON, N.J. (AP) — A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores. The Food and Drug Administration approved the over-the-counter aerosol inhaler late Wednesday. It's for temporary relief of mild, intermittent asthma symptoms in people ages 12 and...
Read More